LDX have multiple functional medtech devices (with more in development and with new development contracts being signed regularly), multiple distributors for their products across multiple nations/continents (USA, Europe, Aus, NZ), and a growing customer base.

LDX also currently have ~ AUD $10 million cash in bank.

Current market cap is about AUD $17 million dollars.

We hold more than half our market cap in cash, not to mention the value of the company, its development contracts, its products, and its growing customer base.

IMO, LDX is significantly undervalued at present.